Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

adMare Bio Innovations

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 8
Rounds per year 2.00
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Health Care
  • Life Science

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of adMare Bio Innovations:
Typical Co-investors
adMare Bio Innovations is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after adMare Bio Innovations:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Canadian Solar Canada, Guelph, Ontario
Coastview Capital California, Los Angeles, United States
Coplex Arizona, Phoenix, United States
Dongfang Ruijia Touzi China, Guangdong, Shenzhen
Drake Enterprises Franklin, North Carolina, United States
Edelweiss Tokio Life Insurance India, Maharashtra, Mumbai
Frost Venture Partners California, San Juan Capistrano, United States
GREE Ventures Chiyoda, Japan
HHIAB -
IQbility Attiki, Greece, Kallithéa
KB Global Platform Fund Seoul, Seoul-t'ukpyolsi, South Korea
Mihe Capital -
Nanshan Venture Capital China, Guangdong, Shenzhen
Poland Prize Program -
Purple Cow Brentwood, California, United States
Sime Darby Kuala Lumpur, Malaysia
Soros Fund Management New York, New York, United States
Times Mirror Interactive California, Los Angeles, United States
Tongjian Tailite Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Epitopea

Biotechnology
Life Science
Therapeutics
24 Oct 2024 Cambridge, Cambridgeshire, United Kingdom

Specific Biologics

Biotechnology
10 Oct 2023 Ontario, California, United States

Inversago Pharma

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
$75M17 Oct 2022 Montreal, Quebec, Canada

Immugenia

Biotechnology
Therapeutics
06 Oct 2022 Sherbrooke, Quebec, Canada

Domain Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$46M10 May 2022 France, Grand Est, France

Specific Biologics

Biotechnology
16 Dec 2021 Ontario, California, United States

Inversago Pharma

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
$35M08 Sep 2020 Quebec

Bright Angel Therapeutics

Biotechnology
03 Dec 2019 Old Toronto, Ontario, Canada

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent adMare Bio Innovations?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 10
Average round size 19M
Rounds per year 2.00
Peak activity year 2022
Lead investments 1
Follow on index 0.20
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Epitopea

Biotechnology
Life Science
Therapeutics
24 Oct 2024 Cambridge, Cambridgeshire, United Kingdom

Specific Biologics

Biotechnology
10 Oct 2023 Ontario, California, United States

Inversago Pharma

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
$75M17 Oct 2022 Montreal, Quebec, Canada

Immugenia

Biotechnology
Therapeutics
06 Oct 2022 Sherbrooke, Quebec, Canada

Domain Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$46M10 May 2022 France, Grand Est, France

Specific Biologics

Biotechnology
16 Dec 2021 Ontario, California, United States

Inversago Pharma

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
$35M08 Sep 2020 Quebec

Bright Angel Therapeutics

Biotechnology
03 Dec 2019 Old Toronto, Ontario, Canada
Crunchbase icon

Content report

The following text will be sent to our editors: